Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma

3Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first recommendations about the management of HCC. Since then, new data have emerged in the literature, prompting the governing board of SBH to sponsor a single-topic meeting in August 2018 in São Paulo. All the invited experts were asked to make a systematic review of the literature reviewing the management of HCC in subjects with cirrhosis. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of updated recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present manuscript is the final version of the reviewed manuscript containing the recommendations of SBH.

Cite

CITATION STYLE

APA

Chagas, A. L., de MATTOS, A. A., Carrilho, F. J., Bittencourt, P. L., Vezozzo, D. C. P., Horvat, N., … Costa, T. de F. A. (2020). Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma. Arquivos de Gastroenterologia, 57. https://doi.org/10.1590/S0004-2803.202000000-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free